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OBJECTIVEdA high amount of subcutaneous fat is suggested to explain the observation of
lower obesity-associated metabolic risk among Inuit than among Europeans. We examined the
association between measures of obesity (visceral adipose tissue [VAT], subcutaneous adipose
tissue [SAT], BMI, waist circumference [WC], and percentage of body fat) and the indices of
glucose metabolism (fasting and 2-h glucose levels, insulin resistance per homeostasis model
assessment [HOMA-IR], and the insulin sensitivity index [ISI0,120]) among Greenland Inuit.
RESEARCH DESIGN AND METHODSdA total of 3,108 adult Inuit participated in a
population-based study. The examination included a 75-g oral glucose tolerance test and an-
thropometric measurements. VAT and SAT were measured by ultrasound according to a vali-
dated protocol. Information on sociodemographic characteristics and health behaviors was
obtained by interview.
RESULTSdMean SATs were 1.8 and 3.5 cm in men and women, respectively. Mean VATs
were 7.0 and 6.3 cm in men and women, respectively. The total prevalence of type 2 diabetes was
9%. Percentage of body fat generally was most strongly associated with all outcomes. Both SAT
and VAT were signiﬁcantly associated with glucose intolerance, fasting and 2-h plasma glucose
levels, HOMA-IR, and ISI0,120. VAT was more strongly associated with all outcomes than was
SAT. After further adjustment for BMI or WC, VAT was associated with glucose intolerance and
insulin resistance, whereas there was a trend toward a negative or no association with SAT.
CONCLUSIONSdHigh mean values of SAT may to a large extent explain the high WC in
Inuit populations, and this is suggested to contribute to the lower observed metabolic risk for a
given level of obesity.
Diabetes Care 36:2988–2994, 2013
A growing body of evidence indicatesthat Inuit populations in the Arctichave high levels of obesity according
to international guidelines for BMI and
waist circumference (WC) (1–3). These
populations are undergoing rapid social
and health transitions, with the emer-
gence of chronic diseases such as type 2
diabetes and ischemic heart disease (4,5).
Among the Inuit, the mean levels of var-
ious cardiovascular risk factors increase
with increasing levels of obesity, as they
do in other populations. The metabolic
impact of different levels of obesity, at
least cross-sectionally, appears to be less
pronounced among the Inuit than
among Europeans, however, especially for
indicators such as HDL cholesterol, trigly-
cerides, blood pressure, and postprandial
glucose and insulin levels (1,6). These
population-speciﬁc differences in levels
of cardiovascular risk factors presumably
depend on interactions among environ-
mental factors, lifestyle, and genetic fac-
tors that inﬂuence obesity and insulin
sensitivity; however, an alternative expla-
nation is that anthropometric measure-
ments such as BMI, waist-to-hip ratio
(WHR), and WC do not reﬂect the same
amount of fat or the same pattern of fat
distribution in different populations.
Evidence is now emerging that par-
ticular patterns of abdominal fat distribu-
tion may confer increased metabolic risk.
Speciﬁcally, excess visceral adipose tissue
(VAT) is thought to be a marker of the
relative inability of subcutaneous adipose
tissue (SAT) to store more energy during
continued positive caloric balance. Indi-
viduals who cannot store their energy
surplus in the SAT would be character-
ized by accumulation of fat at undesired
sites such as the liver, the heart, the
skeletal muscle, and the pancreas (7–10).
To elucidate the role of fat distribu-
tion in obesity-associated metabolic risk
among Greenland Inuit, the overall aim of
the current study was therefore to study
the associations of ultrasound measures
of fat distribution (visceral fat, subcu-
taneous fat, and the ratio of these two
measures), anthropometric measure-
ments (BMI, WC, and percentage of
body fat [fat%]), and the following indices
of glucose metabolism: type 2 diabetes,
impaired fasting glycemia (IFG), im-
paired glucose tolerance (IGT), fasting
and 2-h glucose values, insulin resistance
per homeostasis model assessment
(HOMA-IR), and the insulin sensitivity
index (ISI0,120).
RESEARCH DESIGN AND
METHODS
Participants
Data were collected during 2005–2010 in
stratiﬁed random samples of adult Inuit in
Greenland (11). The total population of
Greenland is 57,000, of whom 90% are
ethnic Greenlanders (Inuit). Genetically,
Greenlanders are Inuit (Eskimos) with an
admixture of European, mainly Scandina-
vian genes. They are genetically and
culturally closely related to the Inuit (Iñu-
piat) in Canada and Alaska and are some-
what more distantly related to the Yupiit
of Alaska and Siberia. Participants were
selected as a stratiﬁed random sample.
Greenland was divided into strata by ge-
ography (southwest coast, central west
coast, northwest coast, east Greenland,
and north Greenland) and community
size (towns with $2000 inhabitants,
towns with ,2000 inhabitants, and vil-
lages with ,500 inhabitants). From each
of these strata, one ormore towns and two
or three villages were selected for the
study as being representative of the stra-
tum with regard to living conditions. A
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random sample was drawn from the cen-
tral population register to obtain around
300 participants from each town; this
number represents the practical limit
for a research team during a visit of 4–6
weeks. Villages were chosen at random in
the strata, and in the selected villages all
adults were invited to participate. Infor-
mation on adults aged $18 years who
had been born in Greenland or Denmark
was collectedduring 2005–2010 in 9 towns
and 13 villages in Greenland. Ethnicity as a
Greenlander was determined at enrolment
on the basis of the primary language of the
participant and self-identiﬁcation.Only one
ethnicity was allowed for each participant.
Interview and questionnaire
The survey questionnaires were devel-
oped in Danish and subsequently trans-
lated into Greenlandic. The translation
procedure included translation by two
or more interpreters, followed by an
independent back translation into Danish
and revision of the translation as needed.
Genetic heritage was estimated from
questions on the ethnicities of the four
grandparents, and if this information was
missing, of the parents. It was subsequently
recoded as full (all grandparents were
Greenlanders) or partial Inuit heritage.
Information on physical activity was
collected using a modiﬁed version of the
long version of the 7-day International
Physical Activity Questionnaire (12). Par-
ticipants were classiﬁed as current smok-
ers, past smokers, or nonsmokers. The
frequency of alcohol consumptionwas re-
ported. Education was recorded as edu-
cational attainment.
Obesity measurements
Height and weight were measured with
the participants wearing underwear and
socks. BMI was calculated as weight in
kilograms divided by height in meters
squared. WC was measured on the stand-
ing participant midway between the iliac
crest and the costal margin. Bioimped-
ance and calculation of fat% were
performed on a leg-to-leg Tanita TBF-
300MA (Tanita Corporation, Tokyo,
Japan). On the basis of a single reading,
fat% was calculated by the internal algo-
rithm of the device, which is based on
height, weight, sex, impedance, and age;
body type was set as standard. An ultra-
sound system (Pie Medical) with a 3C-RS
curved transducer was used to determine
VAT and subcutaneous abdominal fat
thicknesses. According to a validated pro-
tocol, ultrasound VAT was deﬁned as the
depth in centimeters from the peritoneum
to the lumbar spine, and ultrasound sub-
cutaneous abdominal fat was deﬁned as the
depth in centimeters from the skin to the
linea alba (13–15). Both measurements
were obtained from where the xiphoid
line and the WC met. Measurements were
made at the end of a quiet expiration by
applying minimal pressure to ensure no
displacement of the abdominal cavity. Co-
efﬁcients of variation for intraobserver and
interobserver variation were in the range
1.9–5.6%.
Glucose homeostasis markers
At the baseline health examination, ve-
nous blood samples were drawn after a
veriﬁed overnight fast ($8.0 h). After
this, participants received a standard
75-g oral glucose tolerance test, with
blood samples drawn 2 h after the glucose
intake. Participants with known type 2
diabetes did not have an oral glucose tol-
erance test, although fasting venous
plasma glucose was measured. Plasma
samples were immediately put on ice
and spun at 48C within 30 min of sam-
pling. Samples were stored frozen at
2208C and shipped to Steno Diabetes
Center, Gentofte, Denmark, for analyses.
Plasma glucose values (0 and 2 h) were
determined with the Hitachi 912 system
(Roche Diagnostics, Mannheim, Ger-
many). Serum insulin values (0 and 2 h)
were determined by an immunoassay
method (AutoDELFIA; Perkin Elmer,
Waltham, MA). Type 2 diabetes and im-
paired glucose regulation were classiﬁed
according to the World Health Organiza-
tion criteria 1999 (16). The following cat-
egories of glucose tolerance status were
included: normal glucose tolerance,
IGT, IFG, and type 2 diabetes. Type 2
diabetes was deﬁned as fasting plasma
glucose $7.0 mmol/L, 2-h plasma glu-
cose$11.1 mmol/L, or both; IFG was de-
ﬁned as fasting plasma glucose $6.1 and
,7.0 mmol/L and 2-h plasma glucose
,7.8 mmol/L; IGT was deﬁned as fast-
ing plasma glucose ,6.1 and #7.8
mmol/L and 2-h plasma glucose ,11.1
mmol/L (16).
Glycemic indices were derived from
glucose and insulin measures from the
glucose tolerance test. Measures of he-
patic insulin resistance were derived
from homeostasis model assessment:
(HOMA-IR (mmol/L 3 mU/L) = [fast-
ing plasma glucose (mmol/L)] 3 [fast-
ing plasma insulin (pmol/L)]/6.945)/
22.5 (17).
The insulin sensitivity index
(ISI0,120) was calculated according to
Gutt et al. (18) to give an estimate of insu-
lin sensitivity in the peripheral tissues as
follows:
Statistical analysis
Analyses were performed with the SAS
statistical software package (version 9.2;
SAS Institute, Cary, NC). Obesity mea-
sures were standardized to a mean of
0 and SD of 1 to facilitate comparisons.
Variables with a skewed distribution
(HOMA-IR, ISI0,120, alcohol consump-
tion, and energy expenditure) were log-
transformed for analysis and presented
as medians with interquartile ranges. The
b-coefﬁcients were calculated with linear
regression models to assess the association
between 1 SD change in obesity measure
and continuousmarkers of glucose homeo-
stasis. For outcomes thatwere not normally
distributed, the b-coefﬁcients were ex-
pressed as percentage change associated
with 1 SD change in obesity measure.
To evaluate the associations between
the obesity measures and glucose toler-
ance status, a multivariate logistic regres-
sion analysis was performed with diabetes,
IFG, and IGT as dependent variable and
with normal glucose tolerance as the refer-
ence category. Analyses that included
plasma glucose and insulin concentrations
were restricted to those with newly diag-
nosed diabetes.
ISI0;120 ¼

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All multivariate analyses were ad-
justed for age, sex, hormonal replacement
therapy, Inuit heritage, physical activity,
smoking status, and alcohol intake. The
models for SAT and VAT were further
adjusted for WC in separate models. Sex-
interactions were tested by examining the
signiﬁcance of the cross-product between
sex and obesity measures.
Ethics considerations
The studies were ethically approved by
the Commission for Scientiﬁc Research in
Greenland. Participants gave their written
consent after being informed about the
study orally and in writing.
RESULTSdWith a participation rate of
66.1%, the total number of Inuit partic-
ipants in the study was 3,108. The 169
participants without information on obe-
sity or body composition were excluded,
bringing the study base down to 2,939. The
mean age of the participants was 44 years
(range 18–95), and 56% were women.
Compared with nonparticipants, partici-
pants were slightly older (44.4 vs. 43.9
years; P = 0.003), and there were fewer
males (43.5% vs. 50.8%; P , 0.001).
Characteristics of the study base are
presented in Table 1.Median levels ofWC
were high and remarkably similar be-
tween men and women (91 and 90 cm,
respectively) relative to a median BMI of
25 and 26 kg/m2 in men and women, re-
spectively. Mean SATs measured by ultra-
sound were 1.8 cm among men and
3.5 cm among women. Mean VATs mea-
sured by ultrasound were 7.0 cm among
men and 6.3 cm among women.
The total prevalence of type 2 diabe-
tes was 9%, of which 79% of cases were
previously unknown. More than half of
the patients with type 2 diabetes (56%)
were diagnosed on the basis of fasting
values of plasma glucose. Of the patients
without diabetes, 9% had IGT and 19%
had IFG. Table 2 shows the results from
the multivariable adjusted logistic regres-
sion of IFG, IGT, and type 2 diabetes on
the continuous fat measures. The stron-
gest associations were seen for fat% and
WC, with all three binary outcomes hav-
ing odds ratios ranging from 1.43 (1.25–
1.81) for WC and type 2 diabetes to 1.64
(1.31–2.05) for fat% and IFG. While VAT
was strongly associated with all glucose
tolerance categories, the association with
SAT was only modest and not statistically
signiﬁcant for IGT and diabetes. There
was a trend toward a negative association
between SAT/VAT ratio and all outcomes;
however, this was not statistically sig-
niﬁcant. When the model for VAT was
further adjusted for BMI or WC, the asso-
ciations were attenuated; however, most
of them remained signiﬁcant, and the di-
rections of the associations were un-
changed. Adjustment of the model for
SAT for WC or BMI revealed a negative
association between SAT and all outcomes,
although this was only statistically signiﬁ-
cant for the association between SAT and
diabetes.
The multiple adjusted b-coefﬁcients
interpret the effect size of glucose
Table 1dDemographic, behavioral, and clinical characteristics of the study population
Men Women
N 1,277 1,662
Age (years) 45 (35–55) 43 (34–53)
Smoking status, % (n)
Current 66 (840) 69 (1,151)
Previous 21 (267) 9 (316)
Never 13 (168) 11 (191)
Alcohol consumption (units/week) 3.5 (0–12) 1.0 (0–8)
Education, % (n)
Elementary 55 (692) 64 (1,045)
Short 35 (436) 26 (421)
Long 10 (132) 10 (168)
Physical activity energy expenditure (kJ/kg/day) 51 (23–96) 46 (24–73)
Height (m) 169 (163–173) 157 (152–161)
Weight (kg) 71 (62–82) 64 (55–75)
BMI (kg/m2) 25 (22–29) 26 (23–30)
WC (cm) 91 (83–102) 90 (81–101)
Hip circumference (cm) 98 (92–103) 100 (93–107)
WHR 0.94 (0.88–1.0) 0.91 (0.86–0.96)
Fat% 21 (16–33) 34 (28–40)
SAT (cm) 1.8 (1.4–2.5) 3.5 (2.6–5.0)
VAT (cm) 7.0 (5.9–8.9) 6.3 (5.2–7.7)
VAT/SAT ratio 3.4 (2.5–4.9) 1.8 (1.4–2.4)
Fasting plasma glucose (mmol/L) 5.7 (5.3–6.1) 5.5 (5.2–5.9)
2-h plasma glucose (mmol/L) 5.0 (4.0–6.4) 5.7 (4.7–7.0)
Fasting plasma insulin (pmol/L) 33 (22–50) 42 (29–61)
2-h plasma insulin (pmol/L) 64 (31–142) 148 (81–251)
HbA1c (%) 5.7 (5.5–5.9) 5.6 (5.4–5.9)
HbA1c (mmol/mol) 38.8 (36.6–41.0) 37.7 (35.5–41.0)
Data are median (interquartile range) unless otherwise stated.
Table 2dAssociations of obesity measures with glucose intolerance
Determinant
Glucose intolerance status
IFG IGT Diabetes
BMI (kg/m2) 1.28 (1.07–1.54) 1.47 (1.16–1.87) 1.49 (1.18–1.88)
WC (cm) 1.46 (1.23–1.73) 1.45 (1.14–1.83) 1.43 (1.25–1.81)
WHR (%) 1.55 (1.30–1.84) 1.21 (0.97–1.50) 1.30 (1.03–1.65)
Fat% 1.64 (1.31–2.05) 1.57 (1.14–2.15) 1.44 (1.07–1.95)
SAT (cm) 1.26 (1.03–1.53) 1.29 (0.98–1.69) 1.02 (0.75–1.37)
WC adjusted 0.83 (0.61–1.11) 0.91 (0.61–1.39) 0.61 (0.40–0.93)
VAT (cm) 1.42 (1.30–1.68) 1.42 (1.13–1.78) 1.33 (1.08–1.65)
WC adjusted 1.19 (0.92–1.53) 1.06 (1.04–1.08) 1.07 (1.05–1.09)
SAT/VAT (%) 0.94 (0.79–1.12) 0.89 (0.67–1.20) 1.09 (0.88–1.36)
WC adjusted 0.78 (0.61–1.01) 0.85 (0.61–1.19) 0.66 (0.45–0.98)
Data are odds ratio (95%CI) per SD of obesity measures adjusted for age, sex, alcohol intake, smoking status,
and physical activity. Associations for SAT and VAT are further adjusted for WC. n = 2,939.
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homeostasis markers per 1 SD increase in
obesity measures (Fig. 1). For fasting and
2-h plasma glucose, the magnitudes of the
association were similar for BMI, WC,
WHR, fat%, and VAT and stronger than
for SAT (P, 0.001 for SAT vs. VAT com-
parison). No association was seen between
SAT/VAT ratio and plasma glucose. After
further adjustment for WC, VAT was still
signiﬁcantly positively associated with fast-
ing glucose, whereas a negative association
was observed for SAT and SAT/VAT ratio.
The same trend, albeit not statistically sig-
niﬁcant, was seen for 2-h glucose.
There was an interaction between sex
and the association between all obesity
measures and markers of insulin sensitiv-
ity, with stronger associations found
among men (Fig. 2). Analyses were there-
fore performed separately for men and
women. For markers of insulin sensitivity,
1 SD increase in BMI, WC, WHR, fat%, or
VAT was roughly associated with a 30%
increase in HOMA-IR and some 15% de-
crease in ISI0,120. Fat% was signiﬁcantly
stronger associated with HOMA-IR and
the insulin sensitivity index than the other
obesity measures, whereas the association
between SAT/ VAT ratio was less strong
(P , 0.001 for SAT/ VAT ratio vs. WC
comparison). Models with VAT and WC
demonstrated signiﬁcant additional con-
tribution of VAT for all variables.
CONCLUSIONS
Summary
In this study, we examined the association
between markers of fat distribution and
overall obesity and glucose intolerance
and glucose homeostasis markers. Our
ﬁndings are threefold. First, fat% gener-
ally had the strongest association with all
outcomes. Second, both SAT and VAT
were signiﬁcantly associated with glucose
intolerance, fasting and 2-h plasma glu-
cose, HOMA-IR, and ISI0,120. Third, VAT
was more strongly associated with all out-
comes than was SAT or the ratio between
SAT and VAT. After further adjustment for
BMI or WC, VAT was associated with glu-
cose intolerance and insulin resistance,
whereas there was a trend toward a nega-
tive or no association with SAT.
The mean SAT (3.5 and 1.8 cm
among women and men, respectively)
was higher than that of other populations
measured by ultrasound (14,19), whereas
VAT measures were similar to these pop-
ulations. These ﬁndings suggest a large
capacity among Inuit to store energy sub-
cutaneously. Thus our study shows that
the high WC in Inuit populations is to a
large extent explained by a high amount
of subcutaneously stored adipose tissue,
and this may contribute to the apparent
lower cardiometabolic risk for a given
level of obesity compared with western
populations. The VAT is similar to other
populations, however, and mean levels of
other obesity measurements are high and
may explain why the absolute risk of type
2 diabetes is high among Greenland Inuit.
Comparison with other studies
Recent studies have focused on the mag-
nitude of the association between di-
rectly measured VAT (by computed
tomography [CT] imaging) and the risk
of diabetes. The Framingham Heart Study
examined cross-sectionally the association
between abdominal fat distribution deter-
mined by CT and various metabolic risk
factors (7,8). In a large community-based
sample, both SAT and VAT were signiﬁ-
cantly associated with blood pressure,
fasting plasma glucose, lipids, hyperten-
sion, impaired fasting glucose, type 2 di-
abetes, and the metabolic syndrome. For
most risk factors, the association was
stronger with VAT than with SAT. VAT
but not SAT contributed signiﬁcantly to
risk factor variation after adjustment for
BMI and WC. These results add weight
to the hypothesized role of visceral fat
as a pathogenic fat depot of particular
importance.
The Insulin Resistance Atherosclero-
sis Study prospectively examined the
association of VAT and SAT, as deter-
mined from CT imaging, and insulin
sensitivity and b-cell dysfunction with in-
cident diabetes in a Hispanic and African
American population (20). The study
showed that insulin resistance and b-cell
dysfunction predicted diabetes indepen-
dently of VAT and SAT. VAT and SAT
were positively associated with incident
diabetes, VATmore strongly so; however,
the association was no longer signiﬁcant
when all four predictors were modeled
together. This lack of an association of
VAT with diabetes independent of insulin
sensitivity and secretionmay indicate that
these mechanisms partially explain the
link between VAT and diabetes. Similarly,
other studies have demonstrated positive
Figure 1dLinear associations between SDs of obesity measures and plasma glucose homeostasis markers adjusted for age, sex, alcohol intake,
smoking status, and physical activity (black) and further adjusted for WC (gray).
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associations between VAT and glucose in-
tolerance (21–24), but few have yielded
signiﬁcant associations for SAT. SAT has,
however, been shown in some studies to
be more strongly associated with insulin
resistance than VAT (25). Two very small
intervention studies have been conducted
to examine the relation of SAT reduction
with metabolic variables. In a small study
of 15 women who underwent large-
volume liposuction, improvements in
cardiometabolic risk factors were not ob-
served despite the loss of nearly 10 kg of
subcutaneous fat (26). Another study of
30 obese women showed, 6 months after
liposuction, lower insulin resistance; re-
duced concentrations of interleukin-6,
interleukin-18, tumor necrosis factor-a,
and C-reactive protein; and increased se-
rum levels of adiponectin and HDL cho-
lesterol (27). The small sample sizes,
associated low power, and inclusion of
morbidly obese study participants in
these studies make it difﬁcult, however,
to rule out a beneﬁcial effect.
Biological mechanisms
Beall and Goldstein (28) speculated that
subcutaneous deposition of fat might be a
useful genetic adaptation to a cold cli-
mate. A spherical body shape would re-
duce heat elimination, and when exposed
to a cold environment, subcutaneous fat
stores have the advantage that insulation
does not ﬂuctuate with nutritional status.
The physiologists Rode and Shephard
(29) have also suggested that long-term
adaptation to the Arctic cold favors the
deposition of subcutaneous fat, which
stores quickly available fuel for heat pro-
duction in response to cold-induced
catecholamine stimulation. Although sub-
cutaneous fat provides insulation, it is met-
abolically less active and has a limited blood
supply and is thus relatively inﬂexible when
responding to increases in heat ﬂux gener-
ated by physical activity. In support of this
view, the relationship of skin fold readings
to body density among Inuit differed
appreciably from that in a population of
European ancestry (30).
Strengths and limitations
A major strength of this study is the large
number of participants with fat distribu-
tion measured by imaging techniques. In
epidemiology,WC orWHR ratio has thus
far been used to quantify central obesity.
Magnetic resonance imaging (MRI) and
CT are the reference methods for estimat-
ing visceral and subcutaneous fat quanti-
ties and distribution; however, the use of
these methods in an arctic setting as well
as in large-scale studies is limited by their
costs, accessibility, and, in the case of CT,
constraints arising from radiation expo-
sure. The ultrasound method used in the
current study has been validated against
MRI and CT as a way of estimating VAT
and subcutaneous fat distributions in
large-scale studies, where MRI and CT
may not be feasible (13–15).
Unlike some studies of fat distribu-
tion and diabetes, participants with
known diabetes were excluded from anal-
yses that included plasma glucose and
insulin concentrations because of the
Figure 2dLinear associations between SDs of obesity measures and insulin resistance markers by sex adjusted for age, alcohol intake, smoking status,
and physical activity (black) and further adjusted for WC (gray).
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possibility that lifestyle changes or
glucose-lowering agents might inﬂuence
the concentration of glucose and insulin
as a function of obesity. Although the
population approach hindered the use of
gold standard methods of glucose regula-
tion (e.g., the use of a euglycemic clamp
test to determine insulin sensitivity), we
did obtain the most precise measures of
glucose homeostasis achievable in an ep-
idemiological setting.
Conclusion
Among Greenland Inuit, VAT is associ-
ated with glucose intolerance and insulin
resistance independently of clinical an-
thropometric measurements, whereas
there is a trend toward a negative or no
association with SAT. High mean values
of SAT in this population suggest that
the high WC in Inuit populations is to a
large extent explained by a high amount
of subcutaneously stored adipose tissue,
and this may contribute to a lower de-
gree of insulin resistance for a given level
of traditional adiposity measures such
as WC.
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